Chester County News and Community Website
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), headquartered in Wayne, PA, is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced the creation of its new Scientific Advisory Board (SAB), marking a strategic step in advancing its focus on immuno-inflammatory diseases. The …
Aclaris Therapeutics Forms Scientific Advisory Board with Renowned Pulmonology Experts Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has taken bold steps to secure top talent by granting stock options and restricted stock units (RSUs) under its 2024 Inducement Plan. On …
Aclaris Therapeutics Awards Stock Options to Attract Top Talent Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has granted stock options and restricted stock units (RSUs) to multiple new employees, including its recently appointed President and Chief Operating Officer, …
Aclaris Therapeutics Announces New Employee Stock Grants Under 2024 Inducement Plan Read More